Literature DB >> 23012361

Activity, specificity, and probe design for the smallpox virus protease K7L.

Alexander E Aleshin1, Marcin Drag, Naran Gombosuren, Ge Wei, Jowita Mikolajczyk, Arnold C Satterthwait, Alex Y Strongin, Robert C Liddington, Guy S Salvesen.   

Abstract

The K7L gene product of the smallpox virus is a protease implicated in the maturation of viral proteins. K7L belongs to protease Clan CE, which includes distantly related cysteine proteases from eukaryotes, pathogenic bacteria, and viruses. Here, we describe its recombinant high level expression, biochemical mechanism, substrate preference, and regulation. Earlier studies inferred that the orthologous I7L vaccinia protease cleaves at an AG-X motif in six viral proteins. Our data for K7L suggest that the AG-X motif is necessary but not sufficient for optimal cleavage activity. Thus, K7L requires peptides extended into the P7 and P8 positions for efficient substrate cleavage. Catalytic activity of K7L is substantially enhanced by homodimerization, by the substrate protein P25K as well as by glycerol. RNA and DNA also enhance cleavage of the P25K protein but not of synthetic peptides, suggesting that nucleic acids augment the interaction of K7L with its protein substrate. Library-based peptide preference analyses enabled us to design an activity-based probe that covalently and selectively labels K7L in lysates of transfected and infected cells. Our study thus provides proof-of-concept for the design of inhibitors and probes that may contribute both to a better understanding of the role of K7L in the virus life cycle and the design of novel anti-virals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012361      PMCID: PMC3501048          DOI: 10.1074/jbc.M112.388678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells.

Authors:  P H Chen; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

2.  The proteinase polypeptide of adenovirus serotype 2 virions.

Authors:  C W Anderson
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

3.  Crystal structure of the human adenovirus proteinase with its 11 amino acid cofactor.

Authors:  J Ding; W J McGrath; R M Sweet; W F Mangel
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

4.  Characterization of human adenovirus proteinase activity in disrupted virus particles.

Authors:  W J McGrath; A P Abola; D L Toledo; M T Brown; W F Mangel
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

5.  Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Analysis of the role of the amino-terminal peptide of vaccinia virus structural protein precursors during proteolytic processing.

Authors:  P Lee; D E Hruby
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

7.  Proteolytic cleavage of vaccinia virus virion proteins. Mutational analysis of the specificity determinants.

Authors:  P Lee; D E Hruby
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

8.  trans processing of vaccinia virus core proteins.

Authors:  P Lee; D E Hruby
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  A transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K.

Authors:  S S Whitehead; D E Hruby
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 10.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03
View more
  5 in total

1.  Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis.

Authors:  Valeria Lulla; Liis Karo-Astover; Kai Rausalu; Andres Merits; Aleksei Lulla
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

2.  Identification and characterization of Orf virus 050 protein proteolysis.

Authors:  Han Wang; Junyi Jiang; Rui Ding; Xiaoping Wang; Meiying Liao; Jing Shao; Xiaohong Luo; Shuhong Luo; Chaohui Duan
Journal:  Virus Genes       Date:  2017-02-11       Impact factor: 2.198

3.  Capsid protein structure, self-assembly, and processing reveal morphogenesis of the marine virophage mavirus.

Authors:  Diana Born; Lukas Reuter; Ulrike Mersdorf; Melanie Mueller; Matthias G Fischer; Anton Meinhart; Jochen Reinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

4.  Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.

Authors:  Wioletta Rut; Zongyang Lv; Mikolaj Zmudzinski; Stephanie Patchett; Digant Nayak; Scott J Snipas; Farid El Oualid; Tony T Huang; Miklos Bekes; Marcin Drag; Shaun K Olsen
Journal:  Sci Adv       Date:  2020-10-16       Impact factor: 14.136

5.  Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim.

Authors:  B Marshall; H Puthalakath; S Caria; S Chugh; M Doerflinger; P M Colman; M Kvansakul
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.